H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on Lifeward (LFWD) to $4.50 from $13 and keeps a Buy rating on the shares following the Q3 report. The firm says the company’s operational changes, regulatory wins and changes in payor dynamics underway bode well for future growth.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFWD: